Bernard Regidor

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Samuel D. Stampfer, Marissa‐Skye Goldwater, Scott Jew et al. · Leukemia · 2021 · 92 citations · Full text

Vaccination, Vaccine Development, Immunology +5

Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy

Sean Bujarski, Kyle A. Udd, Camilia Soof et al. · Targeted Oncology · 2021 · 18 citations

Hematological Malignancy, Clinical Status, Autoimmune Disease +10

Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination

Samuel D. Stampfer, Marissa‐Skye Goldwater, Sean Bujarski et al. · Clinical Infection in Practice · 2021 · 15 citations · Full text

Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients—a single-center retrospective study

Bernard Regidor, Marissa‐Skye Goldwater, Jessica Wang et al. · Annals of Hematology · 2021 · 13 citations

Hematological Malignancy, Oncology, Immunology +5

Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma

James R. Berenson, Daisy Martinez, Tahmineh Safaie et al. · British Journal of Haematology · 2022 · 11 citations